Application of HoxC11 as biological marker for preparing lung adenocarcinoma pre-diagnostic reagent
A biomarker, hoxc11 technology, applied in biochemical equipment and methods, microbe measurement/test, disease diagnosis, etc., has achieved far-reaching clinical significance and important promotion and application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Example 1 Real-time fluorescent quantitative PCR method detection confirms that HoxC11 is up-regulated in lung adenocarcinoma
[0022] 1. Materials and methods:
[0023] 36 pairs of lung adenocarcinoma and adjacent normal control tissues were collected, total RNA was extracted, 1 μg RNA was reverse transcribed into cDNA, and real-time fluorescent quantitative PCR was performed. HoxC11 forward primer 5'-GAGGCTGAGGAGGAGAACAC-3' (SEQ ID NO.2) and HoxC11 reverse primer 5'-CTTGTCGGTCCGTCAGGTT-3' (SEQ ID NO.3).
[0024] Internal reference gene Beta-actin forward primer 5'-CACCATTGGCAATGAGCGGTTC-3' (SEQ ID NO.4) and internal reference gene Beta-actin reverse primer 5'-AGGTCTTTGCGGATGTCCACGT-3' (SEQ ID NO.5) used for control. The real-time fluorescent quantitative PCR reaction system is as follows:
[0025]
[0026] Real-time fluorescent quantitative PCR reaction steps
[0027]
[0028] After the reaction, the amplification curve and melting curve of real-time fluoresc...
Embodiment 2
[0031] Example 2 Analysis of data in the kaplan meier-plotter (www.kmplot.com) database found that the expression of HoxC11 in lung adenocarcinoma is related to the prognosis of patients.
[0032] result
[0033] The overall survival time of lung adenocarcinoma patients with high expression of HoxC11 is significantly lower than that of patients with low expression of HoxC11, and the prognosis is poor.
Embodiment 3
[0034] Example 3 Constructing an overexpression HoxC11 vector to overexpress HoxC11
[0035] 1. Material method
[0036] 1.1 Reagents and kits
[0037] HOXC11 bacteria solution ThermoCat.MHS6278-202755988
[0038] Restriction enzymes Age I, NheI, T4 DNA ligase, etc. were purchased from TakaRa;
[0039] PLJM1-EGFP(8038bp) addgene
[0040] EcoliDH5α Competent Cells Takara
[0041] TRIZOL TM Reagent (Invitrogen);
[0042] Plasmid Extraction Kit (#D6943-01, OMEGA);
[0043] Gel recovery kit (#M5212, OMEGA);
[0044] Reverse transcription kit (#A3500, Promega);
[0045] The antibiotic puromycin (Ameresc).
[0046] 1.2 Design of HoxC11 (CDS) primers
[0047] Find the HoxC11 (CDS) sequence through the UCSC database, and then design primers through the enzyme-cut protection base database
[0048] F:AGTC GCTAGC ATGTTTAACTCGGTCAACCTG (SEQ ID NO. 6) NheI
[0049] R: CGGGT ACCGGTAGCAGCAGAGGATTTCCCGAGA (SEQ ID NO. 7) AgeI
[0050] Primer description: Contains enzyme-cle...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com